Passage Bio Inc PASG:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.35quote price arrow up+0.06 (+4.65%)
Volume
50,643
52 week range
0.58 - 1.79
Loading...
  • Open1.28
  • Day High1.36
  • Day Low1.27
  • Prev Close1.29
  • 52 Week High1.79
  • 52 Week High Date03/06/24
  • 52 Week Low0.58
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap83.176M
  • Shares Out61.61M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change33.66

KEY STATS

  • Open1.28
  • Day High1.36
  • Day Low1.27
  • Prev Close1.29
  • 52 Week High1.79
  • 52 Week High Date03/06/24
  • 52 Week Low0.58
  • 52 Week Low Date11/13/23
  • Market Cap83.176M
  • Shares Out61.61M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change33.66

RATIOS/PROFITABILITY

  • EPS (TTM)-1.87
  • P/E (TTM)-0.72
  • Fwd P/E (NTM)-1.04
  • EBITDA (TTM)-99.192M
  • ROE (TTM)-65.29%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Passage Bio Inc

 

Profile

MORE
Passage Bio, Inc. is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Its clinical product candidate, PBFT02, seeks to elevate progranulin levels to restore lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus capsid to deliver a functional granulin gene, or GRN, encoding progranulin to the brain via intra cisterna magna...
Maxine Gowen Ph.D.
Independent Chairwoman of the Board
William Chou M.D.
President, Chief Executive Officer, Director
Kathleen Borthwick
Chief Financial Officer
Edgar Cale
General Counsel, Company Secretary
Address
One Commerce Square
2005 Market Street, 39Th Floor
Philadelphia, PA
19103
United States

Top Peers

SYMBOLLASTCHG%CHG
SLS
Sellas Life Sciences Group Inc
1.28+0.04+3.23%
CMRX
Chimerix Inc
0.95+0.01+1.0638%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
3.26+0.20+6.54%
TPST
Tempest Therapeutics Inc
3.62+0.15+4.32%
CGTX
Cognition Therapeutics Inc
1.95+0.04+2.09%